Remove Biopharma Remove Biopharmaceuticals Remove Construction
article thumbnail

Top 12 BioPharma / Pharmaceutical Recruiters, Headhunters, and Executive Search Firms

Jake Jorgovan

If you’re in the BioPharma and Pharmaceutical industries, your most valuable resource isn’t just the latest breakthrough drug or cutting-edge technology. Enter the world of executive search firms, headhunters, and recruiters specializing in the BioPharma and Pharmaceutical industries. Let’s dive in.

Biopharma 130
article thumbnail

Discover Six Dynamic Trends to Disrupt the Next Generation of Biopharmaceutical Manufacturing

Frost & Sullivan

May 12, 2021 – The biopharmaceutical industry is facing its biggest test in recent times. A rise in new disease outbreaks, the urgency to launch innovative therapies, and new constructs such as multi-valent antibodies are compelling biopharmaceutical companies to adopt new manufacturing approaches. SANTA CLARA, Calif. –

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top 14 Healthcare IT & Technology Consultants & Consulting Firms

Jake Jorgovan

Biopharmaceutical Consulting: Supporting every aspect of the biopharma value chain, including R&D, operations, manufacturing, commercialization, and mergers and acquisitions (M&A). Their services are utilized across multiple industries including construction, banking, retail, education, and healthcare.

article thumbnail

Growth Perspectives: Key Highlights from DCAT 2024

Frost & Sullivan

Fuelling Growth: Strategic Investments, Acquisitions, and Expansions Samsung Biologics unveiled plans to expand capacity and geographic reach by initiating the construction of Bio Campus II with a $6 billion investment scheduled to begin operations in 2025 while completing its CGMP antibody-drug conjugate manufacturing facility within 2024.